Severity of psoriasis associated with metabolic syndrome
Închide
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
33 0
SM ISO690:2012
STĂNESCU, Alexandra Ana Maria; STEFANI, Constantin; GRAJDEANU, Ioana Veronica; SERBAN, Bogdan; CIOBANU, Gheorghe; DIACONU, Camelia. Severity of psoriasis associated with metabolic syndrome. In: Revista de Chimie. 2019, nr. 6(70), pp. 2072-2079. ISSN 0034-7752.
EXPORT metadate:
Google Scholar
Crossref
CERIF
BibTeX
DataCite
Dublin Core
Revista de Chimie
Numărul 6(70) / 2019 / ISSN 0034-7752

Severity of psoriasis associated with metabolic syndrome


Pag. 2072-2079

Stănescu Alexandra Ana Maria1, Stefani Constantin1, Grajdeanu Ioana Veronica1, Serban Bogdan12, Ciobanu Gheorghe3, Diaconu Camelia14
 
1 University of Medicine and Pharmacy “Carol Davilla”, Bucharest,
2 Emergency University Hospital Bucharest,
3 ”Nicolae Testemițanu” State University of Medicine and Pharmacy,
4 Clinical Emergency Hospital of Bucharest
 
Disponibil în IBN: 16 august 2019


Rezumat

Although extensively studied, psoriasis still has negative consequences and is associated with multiple comorbidities, including metabolic syndrome. The severity of psoriasis seems to influence the occurrence of diagnostic criteria for metabolic syndrome. 208 patients diagnosed with psoriasis were identified, who were divided into lots depending on the severity of psoriasis, but also to the presence or absence of metabolic syndrome. Interpretation of statistical data was done with SPSS V21 (Statistical Package for Social Science) and MEDCALC (Statistical Software). The coexistence of severe psoriasis with metabolic syndrome increases the risk of developing cardiovascular diseases by 2.97 or greater, with a confidence interval of [1.60, 5.51], than that of patients with severe psoriasis who have no metabolic syndrome. The hypothesis was statistically confirmed by p = 0.003. Analyzing the total group with psoriasis by severity, we found the following distribution: From the total number of 208 patients, 39 (18.8%) had severe psoriasis, 83 (39.9%) moderate psoriasis and 86 (41.3%) mild psoriasis. The higher incidence of metabolic syndrome in patients with psoriasis is evidenced by the Pearson Chi-Square test, where p <0.001. The association of metabolic syndrome in patients with psoriasis is evident. The more severe the psoriasis, the more likely it is to develop metabolic syndrome.

Cuvinte-cheie
cardiovascular diseases, metabolic syndrome, psoriasis